Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2011 Sep 14;17(34):3948-52.
doi: 10.3748/wjg.v17.i34.3948.

Severe chronic diarrhea and maculopapular rash: a case report

Affiliations
Case Reports

Severe chronic diarrhea and maculopapular rash: a case report

Alessandra Elvevi et al. World J Gastroenterol. .

Abstract

Systemic mastocytosis (SM) is a heterogeneous disease of the bone marrow characterized by abnormal growth, accumulation and activation of clonal mast cells (MCs). We report a case of SM with multi-organ involvement. A 30-year-old man presented with diarrhea, flushing, maculopapular rash with itching and weight loss. The upper and lower gastrointestinal endoscopies showed macroscopic involvement of stomach and duodenum; mucosal samples from stomach, duodenum, colon and distal ileum showed mucosal infiltration by large, spindle-shaped MCs with abnormal surface molecule expression (CD2 and CD25), a picture fully consistent with SM, according to the World Health Organization diagnostic criteria. A computed tomography scan showed diffuse lymphadenopathy, hepatosplenomegaly and diffuse small bowel involvement. Bone marrow aspirate and biopsy were diagnostic for SM; serum tryptase levels were increased (209 ng/mL, normal values < 20 ng/mL). The conclusive diagnosis was smouldering SM. There were no therapeutic indications except for treatment of symptoms. The patient was strictly followed up because of the risk of aggressive evolution.

Keywords: Bone marrow; Mast cells; Systemic mastocytosis; Tryptase.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Maculopapular rash (“urticaria pigmentosa”) in a systemic mastocytosis patient.
Figure 2
Figure 2
Abdominal ultrasound. A: Small bowel dilatation and wall edema at ultrasonography (US). B: Abdominal lymphadenopathy at US (crosses refer to lymph node enlargement, 5 cm).
Figure 3
Figure 3
Colon biopsy in a systemic mastocytosis patient. A: Diffuse mast cell (MC) infiltrate (Hematoxylin-eosin, × 10); B: The dense infiltrate is represented by MCs, whose detection is increased by positive immunohistochemical marker CD117; C: The dense infiltrate is represented by MCs, whose detection is increased by positive immunohistochemical marker CD25.
Figure 4
Figure 4
Bone marrow biopsy in a systemic mastocytosis patient. A: Diffuse mast cell (MC) infiltrate (Hematoxylin-eosin, × 10); B: The dense infiltrate is represented by MCs, whose detection is increased by positive immunohistochemical marker CD117; C: The dense infiltrate is represented by MCs, whose detection is increased by positive immunohistochemical marker CD25.

References

    1. Horny HP, Sotlar K, Valent P. Mastocytosis: state of the art. Pathobiology. 2007;74:121–132. - PubMed
    1. Rosen T. Rare hematological malignancies. 9th ed. New York: Springer; 2008. pp. 399–419.
    1. Valent P, Akin C, Sperr WR, Horny HP, Arock M, Lechner K, Bennett JM, Metcalfe DD. Diagnosis and treatment of systemic mastocytosis: state of the art. Br J Haematol. 2003;122:695–717. - PubMed
    1. Hungness SI, Akin C. Mastocytosis: advances in diagnosis and treatment. Curr Allergy Asthma Rep. 2007;7:248–254. - PubMed
    1. Valent P, Akin C, Escribano L, Födinger M, Hartmann K, Brockow K, Castells M, Sperr WR, Kluin-Nelemans HC, Hamdy NA, et al. Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria. Eur J Clin Invest. 2007;37:435–453. - PubMed

Publication types